Lifelong antiretroviral therapy or HIV cure: The benefits for the individual patient

References

• Achenbach, C. J., Assoumou, L., Deeks, S. G., Wilkin, T. J., Berzins, B., Casazza, J. P., … Murphy, R. L. (2015). Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial. The Lancet HIV, 2(3), e82–e91. doi:10.1016/S2352-3018(15)00026-0
   PubMed Web of Science ®Google Scholar
• Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., … Margolis, D. M. (2012). Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature, 487(7408), 482–485. doi:10.1038/nature11286
   PubMed Web of Science ®Google Scholar
• Arhaus, U. o. (2014). Safety and effect of The HDAC inhibitor panobinostat on HIV-1 expression in patients on suppressive HAART (CLEAR). Bethsheda, MD: National Library of Medicine (US): clinicaltrials.gov.
   Google Scholar
• Baker, J. V., Peng, G., Rapkin, J., Abrams, D. I., Silverberg, M. J., MacArthur, R. D., …  Terry Beirn Community Programs for Clinical Research on, A. (2008). CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS, 22(7), 841–848. doi:10.1097/QAD.0b013e3282f7cb76
   PubMed Web of Science ®Google Scholar
• Choi, J. Y. (2013). Mental Health of HIV-infected patients: A severe, but overlooked problem. Infection & Chemotherapy, 45(2), 239–240. doi: 10.3947/ic.2013.45.2.239
   PubMedGoogle Scholar
• Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J. C., … Emini, Emilio A. (1995). In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature, 374(6522), 569–571. doi:10.1038/374569a0
   PubMed Web of Science ®Google Scholar
• Deeks, S. G. (2011). HIV infection, inflammation, immunosenescence, and aging. Annual Review of Medicine, 62, 141–155. doi:10.1146/annurev-med-042909-093756
   PubMed Web of Science ®Google Scholar
• Department of Health. (2013). The management of HIV – infected healthcare workers: Department of Health's response to consultation.
   Google Scholar
• Hayden, E. C. (2013). Hopes of HIV cure in “Boston patients” dashed.
   Google Scholar
• Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müßig, A., Allers, K., … Blau, O. (2009). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. New England Journal of Medicine, 360(7), 692–698. doi: 10.1056/NEJMoa0802905
   PubMed Web of Science ®Google Scholar
• Ickovics, J. R., Cameron, A., Zackin, R., Bassett, R., Chesney, M., Johnson, V. A., … Adult, A. C. T. G. P. T. (2002). Consequences and determinants of adherence to antiretroviral medication: Results from Adult AIDS Clinical Trials Group protocol 370. Antiviral Therapy, 7(3), 185–193.
   PubMed Web of Science ®Google Scholar
• Kacanek, D., Jacobson, D. L., Spiegelman, D., Wanke, C., Isaac, R., & Wilson, I. B. (2010). Incident depression symptoms are associated with poorer HAART adherence: A longitudinal analysis from the nutrition for healthy living study. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 53(2), 266–272. doi: 10.1097/QAI.0b013e3181b720e7
   PubMed Web of Science ®Google Scholar
• Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013). Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. Journal of the International AIDS Society, 16(3 Suppl 2), 18640. doi:10.7448/ias.16.3.18640
   PubMed Web of Science ®Google Scholar
• Kelley, C. F., Kitchen, C. M., Hunt, P. W., Rodriguez, B., Hecht, F. M., Kitahata, M., … Deeks, S. G. (2009). Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical Infectious Diseases, 48(6), 787–794. doi:10.1086/597093
   PubMed Web of Science ®Google Scholar
• Kitara, D. L., & Aloyo, J. (2012). HIV/AIDS stigmatization, the reason for poor access to HIV counseling and testing (HCT) among the youths in Gulu (Uganda). Afr J Infect Dis, 6(1), 12–20.
   PubMedGoogle Scholar
• Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., … Bangsberg, D. R. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA, 296(6), 679–690. doi:10.1001/jama.296.6.679
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Hsu, A. J., Uthman, O. A., Spinewine, A., & Pham, P. A. (2012). Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population. AIDS, 26(Suppl 1), S39–S53. doi: 10.1097/QAD.0b013e32835584ea
   PubMedGoogle Scholar
• Nachega, J. B., Parienti, J. J., Uthman, O. A., Gross, R., Dowdy, D. W., Sax, P. E., … Giordano, T. P. (2014). Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clinical Infectious Diseases, 58(9), 1297–1307. doi:10.1093/cid/ciu046
   PubMed Web of Science ®Google Scholar
• National Institute of Allergy and Infectious Diseases, N. I. o. H. (2014). “Mississippi baby” now has dectectable HIV, researchers find [press release]. Retrieved from http://www.niaid.nih.gov/news/newsreleases/2014/Pages/MississippiBabyHIV.aspx
   Google Scholar
• Nii-Trebi, N. I., Ibe, S., Barnor, J. S., Ishikawa, K., Brandful, J. A., Ofori, S. B., … Sugiura, W. (2013). HIV-1 drug-resistance surveillance among treatment-experienced and -naive patients after the implementation of antiretroviral therapy in Ghana. PloS One, 8(8), e71972–e71972. doi:10.1371/journal.pone.0071972
   Google Scholar
• Nyirenda, M., Chatterji, S., Rochat, T., Mutevedzi, P., & Newell, M. L. (2013). Prevalence and correlates of depression among HIV-infected and -affected older people in rural South Africa. Journal of Affective Disorders, 151(1), 31–38. doi: 10.1016/j.jad.2013.05.005
   PubMed Web of Science ®Google Scholar
• Odimegwu, C., Adedini, S. A., & Ononokpono, D. N. (2013). HIV/AIDS stigma and utilization of voluntary counselling and testing in Nigeria. BMC Public Health, 13, 465. doi:10.1186/1471-2458-13-465
   PubMed Web of Science ®Google Scholar
• Okulicz, J. F., Grandits, G. A., French, J. A., George, J. M., Simpson, D. M., Birbeck, G. L., … Landrum, M. L. (2011). Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: A retrospective case control study. AIDS Research & Therapy [Electronic Resource], 8, 18. doi:10.1186/1742-6405-8-18
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. doi: 10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Pearson, C. R., Micek, M. A., Pfeiffer, J., Montoya, P., Matediane, E., Jonasse, T., … Gloyd, S. S. (2009). One year after ART initiation: Psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS and Behavior, 13(6), 1189–1196. doi:10.1007/s10461-009-9596-0
   PubMed Web of Science ®Google Scholar
• Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T.-W., … Luzuriaga, K. (2013). Absence of detectable HIV-1 viremia after treatment cessation in an infant. New England Journal of Medicine, 369(19), 1828–1835. doi:10.1056/NEJMoa1302976
   PubMed Web of Science ®Google Scholar
• Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988). Fidelity of HIV-1 reverse transcriptase. Science, 242(4882), 1168–1171. doi: 10.1126/science.2460924
   PubMed Web of Science ®Google Scholar
• Rasmussen, T. A., Schmeltz Sogaard, O., Brinkmann, C., Wightman, F., Lewin, S. R., Melchjorsen, J., … Tolstrup, M. (2013). Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation. Human Vaccines & Immunotherapeutics, 9(5), 993–1001. doi:10.4161/hv.23800
   PubMed Web of Science ®Google Scholar
• Richman, D. D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S. A., … Pauletti, D. (1994). Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. Journal of Virology, 68(3), 1660–1666.
   PubMed Web of Science ®Google Scholar
• Rintamaki, L. S., Davis, T. C., Skripkauskas, S., Bennett, C. L., & Wolf, M. S. (2006). Social stigma concerns and HIV medication adherence. AIDS Patient Care and STDS, 20(5), 359–368. doi:10.1089/apc.2006.20.359
   PubMed Web of Science ®Google Scholar
• Saez-Cirion, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., … Group, A. V. S. (2013). Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathogens, 9(3), e1003211. doi:10.1371/journal.ppat.1003211
   PubMed Web of Science ®Google Scholar
• Sayles, J. N., Ryan, G. W., Silver, J. S., Sarkisian, C. A., & Cunningham, W. E. (2007). Experiences of social stigma and implications for healthcare among a diverse population of HIV positive adults. Journal of Urban Health, 84(6), 814–828. doi: 10.1007/s11524-007-9220-4
   PubMed Web of Science ®Google Scholar
• Søgaard, O. S., Graversen, M. E., Leth, S., Brinkmann, C., Kjær, A.-S., Olesen, R., … Tolstrup, M. (2014, July). The HDAC Inhibitor Romidepsin is safe and Effectively Reverses HIV-1 latency in vivo as Measured by Standard Clinical Assays. Paper presented at the 20th International AIDS conference, Melborne.
   Google Scholar
• Sterne, J. A. C., Hernán, M. A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P., … Egger, M. (2005). Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study. The Lancet, 366(9483), 378–384. doi:10.1016/s0140-6736(05)67022-5
   PubMed Web of Science ®Google Scholar
• The Strategies for Management of Antiretroviral Therapies Study, G. (2006). CD4+ count-guided interruption of antiretroviral treatment. New England Journal of Medicine (355), 2283–2296. doi:10.1056/NEJMoa062360
   PubMed Web of Science ®Google Scholar
• Tebas, P., Stein, D., Tang, W. W., Frank, I., Wang, S. Q., Lee, G., … June, C. H. (2014). Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. New England Journal of Medicine, 370(10), 901–910. doi:10.1056/NEJMoa1300662
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2012). UNAIDS report on the global AIDS epidemic. In U. N. J. P. o. HIV/AIDS (Ed.). Retrieved from http://www.unaids.org/sites/default/files/media_asset/20121120_UNAIDS_Global_Report_2012_with_annexes_en_1.pdf
   Google Scholar
• UNAIDS. (2014). The Gap Report. In U. N. J. P. o. HIV/AIDS (Ed.). Retrieved from http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2014/july/20140716prgapreport/
   Google Scholar
• West, A. P.Jr., Scharf, L., Scheid, J. F., Klein, F., Bjorkman, P. J., & Nussenzweig, M. C. (2014). Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell, 156(4), 633–648. doi:10.1016/j.cell.2014.01.052
   PubMed Web of Science ®Google Scholar